Publication 2023 6

Performance of baseline FDG-PET/CT radiomics for prediction of bone marrow minimal residual disease status in the LyMa-101 trial. Bodet-Milin C, Morvant C, Carlier T, Frecon G, Tournilhac O, Safar V, et al. Sci Rep. 24 oct 2023;13(1):18177. https://doi.org/10.1038/s41598-023-45215-y